Cargando…
Evaluation of the impact of transient interruption of antiangiogenic treatment using ultrasound-based techniques in a murine model of hepatocellular carcinoma
BACKGROUND: Development of escape pathways from antiangiogenic treatments was reported to be associated with enhanced tumor aggressiveness and rebound effect was suggested after treatment stop. Aim of the study was to evaluate tumor response simulating different conditions of administration of antia...
Autores principales: | Marinelli, Sara, Salvatore, Veronica, Toaldo, Marco Baron, Milazzo, Maddalena, Croci, Luca, Venerandi, Laura, Pecorelli, Anna, Palamà, Chiara, Diana, Alessia, Bolondi, Luigi, Piscaglia, Fabio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4057590/ https://www.ncbi.nlm.nih.gov/pubmed/24902850 http://dx.doi.org/10.1186/1471-2407-14-403 |
Ejemplares similares
-
Circulating microRNAs, miR-939, miR-595, miR-519d and miR-494, Identify Cirrhotic Patients with HCC
por: Fornari, Francesca, et al.
Publicado: (2015) -
Corrigendum: Vidatox 30 CH has tumor activating effect in hepatocellular carcinoma
por: Giovannini, Catia, et al.
Publicado: (2017) -
Venom from Cuban Blue Scorpion has tumor activating effect in hepatocellular carcinoma
por: Giovannini, Catia, et al.
Publicado: (2017) -
Metronomic Capecitabine in Patients With Hepatocellular Carcinoma Unresponsive to or Ineligible for Sorafenib Treatment: Report of Two Cases
por: Marinelli, Sara, et al.
Publicado: (2013) -
Antiangiogenic VEGF Isoform in Inflammatory Myopathies
por: Volpi, Nila, et al.
Publicado: (2013)